TY - JOUR
T1 - 2021 CSANZ and ANZSCTS Position Statement on the Operator and Institutional Requirements for a Transcatheter Aortic Valve Implantation (TAVI) Program in Australia
AU - Bennetts, Jayme
AU - Sinhal, Ajay
AU - Walters, Darren
AU - MacIsaac, Andrew
AU - Fayers, Trevor
AU - Lo, Sidney
AU - Almeida, Aubrey
AU - Muller, David W.M.
N1 - Funding Information:
Jayme Bennetts: - Advisory Board member Medtronic, Edwards Lifesciences, Abbott Medical, and Liva Nova. Proctor Medtronic and Edwards Lifesciences. Research grant support Edwards Lifesciences , Medtronic , and Abbott Medical .
Funding Information:
David W.M. Muller: - Advisory Board member and consultant to Medtronic, Boston Scientific; consultant to Abbott Vascular; research grant support Abbott Vascular , Medtronic ; proctor for Medtronic , Abbott Vascular .
Funding Information:
Jayme Bennetts: - Advisory Board member Medtronic, Edwards Lifesciences, Abbott Medical, and Liva Nova. Proctor Medtronic and Edwards Lifesciences. Research grant support Edwards Lifesciences, Medtronic, and Abbott Medical.Ajay Sinhal: - Advisory Board member Medtronic, Edwards Lifesciences, and Boston Scientific. Proctor Medtronic and Edwards Lifesciences. Research grant support Edwards Lifesciences and Medtronic.David W.M. Muller: - Advisory Board member and consultant to Medtronic, Boston Scientific; consultant to Abbott Vascular; research grant support Abbott Vascular, Medtronic; proctor for Medtronic, Abbott Vascular.
Publisher Copyright:
© 2021 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ)
PY - 2021/12
Y1 - 2021/12
N2 - This document establishes the minimum standard for accreditation of institutions and operators as endorsed by the Cardiac Society of Australia and New Zealand (CSANZ) and the Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS). The original Joint Society Position Statement was ratified in August 2014. This 2021 update replaces the original and serves as a consensus within which the Conjoint Committee for Trancatheter Aortic Valve Implantation (TAVI) Accreditation will function, as recommended by Medical Services Advisory Committee (MSAC) Determination for TAVI. This is not a Guideline Statement but takes into consideration regional, legislative, and health system factors important to establishing requirements for TAVI accreditation in Australia.
AB - This document establishes the minimum standard for accreditation of institutions and operators as endorsed by the Cardiac Society of Australia and New Zealand (CSANZ) and the Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS). The original Joint Society Position Statement was ratified in August 2014. This 2021 update replaces the original and serves as a consensus within which the Conjoint Committee for Trancatheter Aortic Valve Implantation (TAVI) Accreditation will function, as recommended by Medical Services Advisory Committee (MSAC) Determination for TAVI. This is not a Guideline Statement but takes into consideration regional, legislative, and health system factors important to establishing requirements for TAVI accreditation in Australia.
KW - Aortic valve replacement
KW - Aortic valve stenosis
KW - Operator requirements
KW - Transcatheter valve therapy
UR - http://www.scopus.com/inward/record.url?scp=85114348661&partnerID=8YFLogxK
U2 - 10.1016/j.hlc.2021.07.017
DO - 10.1016/j.hlc.2021.07.017
M3 - Article
C2 - 34483050
AN - SCOPUS:85114348661
SN - 1443-9506
VL - 30
SP - 1811
EP - 1818
JO - Heart Lung and Circulation
JF - Heart Lung and Circulation
IS - 12
ER -